Purified cytokine inhibitory factor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 1, 2006
Issued Date -
N/A
app pub date -
Feb 11, 2003
filing date -
Feb 11, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-.alpha.), interleukin-1-beta (IL-1.beta.), and interleukin-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully